Evidence map›Paper›PMID 35242798›Full record

ArticleFrontiers in nutrition2022

A Nutrient Formulation Affects Developmental Myelination in Term Infants: A Randomized Clinical Trial.

Nora Schneider, Muriel M K Bruchhage, Barry V O'Neill, Mickaël Hartweg, Jérôme Tanguy, Pascal Steiner, Gisella Mutungi, Jonathan O'Regan, Séamus Mcsweeney, Viren D'Sa and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03111927 (The Effect of Myelin-Relevant Nutrients in Infant Formula on Brain Myelination and Cognitive Development), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03111927 nacompletednot on this map

The Effect of Myelin-Relevant Nutrients in Infant Formula on Brain Myelination and Cognitive Development

TypeinterventionalSponsorSociété des Produits Nestlé (SPN)Ran2017 to 2022Enrolled189ConditionsHealthy, Infant DevelopmentArmsInfant Formula: enriched level of myelin-relevant nutrients, Infant formula: standard level of myelin-relevant nutrients
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Nora SchneiderNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé SA, Lausanne, Switzerland.
Muriel M K BruchhageDepartment of Pediatrics, Brown University, Providence, RI, United States.
Barry V O'NeillNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé SA, Lausanne, Switzerland.
Mickaël HartwegClinical Research Unit, Nestlé Research, Société des Produits Nestlé SA, Lausanne, Switzerland.
Jérôme TanguyClinical Research Unit, Nestlé Research, Société des Produits Nestlé SA, Lausanne, Switzerland.
Pascal SteinerNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé SA, Lausanne, Switzerland.
Gisella MutungiNestlé Nutrition, Société des Produits Nestlé SA, Vevey, Switzerland.
Jonathan O'ReganNestlé Development Centre Nutrition, Askeaton, Ireland.
Séamus McsweeneyNestlé Development Centre Nutrition, Askeaton, Ireland.
Viren D'SaDepartment of Pediatrics, Brown University, Providence, RI, United States.
Sean C L DeoniDepartment of Pediatrics, Brown University, Providence, RI, United States.
Nestlé (Switzerland) · CHHasbro Children's Hospital · USBrown University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesObservational studies suggest differences between breast-fed and formula-fed infants in developmental myelination, a key brain process for learning. The study aims to investigate the efficacy of a blend of docosahexaenoic acid (DHA), arachidonic acid (ARA), iron, vitamin B12, folic acid, and sphingomyelin (SM) from a uniquely processed whey protein concentrate enriched in alpha-lactalbumin and phospholipids compared with a control formulation on myelination, cognitive, and behavioral development in the first 6 months of life.

methodsThese are 6-month results from an ongoing two-center, randomized controlled trial with a 12-month intervention period (completed for all participants). In this study, full term, neurotypical infants of both sexes (

resultsThe full analyses set comprises

conclusionsThis is the first study demonstrating the efficacy of a myelin nutrient blend in well-nourished, term infants on developmental myelination, which may be foundational for later cognitive and learning outcomes. CLINICAL

trial registrationClinicalTrials.gov, identifier: NCT03111927.

Indexed as

brain developmentinfant nutritionMRImyelinationphospholipids

Identifiers

PMID35242798
PMCPMC8886575
OpenAlexW4210987484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.